Complexo Hospitalario Universitario de Vigo
Centro de atención
![Foto de Complexo Hospitalario Universitario de Vigo](/img/noimage.png)
![Foto de Hospital Virgen de La Luz de Cuenca](/img/noimage_org.png)
Hospital Virgen de La Luz de Cuenca
Cuenca, EspañaPublicacións en colaboración con investigadores/as de Hospital Virgen de La Luz de Cuenca (20)
2023
-
A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism
Thrombosis Update, Vol. 13
-
Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP
Journal of Clinical Medicine, Vol. 12, Núm. 14
-
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry
Journal of Crohn's & colitis, Vol. 17, Núm. 1, pp. 83-91
-
Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations
British Journal of Haematology, Vol. 201, Núm. 5, pp. 971-981
-
Women in urology: What is their current situation in Spain?
Actas Urologicas Espanolas, Vol. 47, Núm. 7, pp. 462-469
2022
-
Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial
Journal of Clinical Medicine, Vol. 11, Núm. 19
-
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry
Journal of Clinical Medicine, Vol. 11, Núm. 2
-
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)
Journal of Clinical Medicine, Vol. 11, Núm. 24
2021
-
Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry
Journal of Crohn's and Colitis, Vol. 15, Núm. 11, pp. 1846-1851
-
Erratum: Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): A secondary analysis of the WAPM study on COVID-19 (Journal of Perinatal Medicine (2020) 48:9 (950-958) DOI: 10.1515/jpm-2020-0355)
Journal of Perinatal Medicine
-
Management of acquired hemophilia A: results from the Spanish registry
Blood Advances, Vol. 5, Núm. 19, pp. 3821-3829
-
Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection
Ultrasound in Obstetrics and Gynecology, Vol. 57, Núm. 2, pp. 232-241
2020
-
Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): A secondary analysis of the WAPM study on COVID-19
Journal of Perinatal Medicine, Vol. 48, Núm. 9, pp. 950-958
2018
-
Real world patient-reported outcomes in HIV-infected adults switching to EVIPLERA®, because of a previous intolerance to cART. PRO-STR study
Current HIV Research, Vol. 16, Núm. 6, pp. 425-435
2017
-
HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study
HIV Clinical Trials, Vol. 18, Núm. 3, pp. 126-134
2016
-
Potential risk for inappropriate dyslipidemia screening in Primary Care in Spain
Revista del Laboratorio Clinico, Vol. 9, Núm. 2, pp. 48-53
-
Request of thyroid function tests from Primary Care in Spain
Endocrinologia y Nutricion, Vol. 63, Núm. 1, pp. 19-26
2014
-
A study of the differences in the request of glycated hemoglobin in primary care in Spain: A global, significant, and potentially dangerous under-request
Clinical Biochemistry, Vol. 47, Núm. 12, pp. 1104-1107
-
Variation in laboratory tests ordered for patients treated in hospital emergency departments
Emergencias, Vol. 26, Núm. 6, pp. 450-458
2008
-
Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277